Literature DB >> 14758545

Interaction of immune complexes isolated from hepatitis C virus-infected individuals with human cell lines.

Rafael Marino1, Leopoldo Deibis, Juan B De Sanctis, Nicolas E Bianco, Felix Toro.   

Abstract

We investigated the interaction of immune complexes (IC) isolated from hepatitis C virus (HCV)-infected individuals with several cell lines that differentially express Fc receptors, and analyzed viral infection by the presence of HCV RNA sequences. Monocytic (U937 and Monomac-6) and lymphocytic (MOLT-4 and Jurkat) cell lines were incubated with interferon- plus phorbol myristate acetate to stimulate the expression of Fc receptors before addition of IC. Cell interaction with IC was monitored by flow cytometry. Positive cell fluorescence was detected in U937 and Monomac-6 cells [mean fluorescence intensity (MFI) 10.56+/-0.8 and 11.60+/-0.8, respectively]. Incubation of cells with monoclonal antibodies against Fc receptors for IgG before addition of IC decreased MFI in both cell lines (U937 2.1+/-0.5, Monomac-6 4.4+/-0.8, P<0.001), indicating that cell-IC interaction through these receptors was inhibited. In particular, the blockage of FcgammaRII was responsible for this effect. No binding of IC with either MOLT-4 or Jurkat cell lines was detected, which correlated with a very low Fc receptor expression. HCV RNA sequences were identified in the cells up to 120 h of post incubation with IC. These results suggest that IC can mediate entry of HCV to both U-937 and Monomac-6 cell lines mainly through the FcgammaRII.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 14758545     DOI: 10.1007/s00430-003-0216-8

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  35 in total

1.  Distribution of hepatitis C virus (HCV) RNA in whole blood and blood cell fractions: plasma HCV RNA analysis underestimates circulating virus load.

Authors:  W N Schmidt; P Wu; J Q Han; M J Perino; D R LaBrecque; J T Stapleton
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

2.  Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.

Authors:  R Thomssen; S Bonk; A Thiele
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

3.  Physiological aspects of circulating immune complexes in the normal population.

Authors:  C E Contreras; A Orozco; P Sánchez; G Ortega; N E Bianco
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

4.  Increased peroxide production by polymorphonuclear cells of chronic hepatitis C virus-infected patients.

Authors:  F Toro; A Conesa; A Garcia; N E Bianco; J B De Sanctis
Journal:  Clin Immunol Immunopathol       Date:  1998-08

5.  Follicular dendritic cells and human immunodeficiency virus infectivity.

Authors:  S L Heath; J G Tew; J G Tew; A K Szakal; G F Burton
Journal:  Nature       Date:  1995-10-26       Impact factor: 49.962

6.  Infection of peripheral mononuclear blood cells by hepatitis C virus.

Authors:  A L Zignego; D Macchia; M Monti; V Thiers; M Mazzetti; M Foschi; E Maggi; S Romagnani; P Gentilini; C Bréchot
Journal:  J Hepatol       Date:  1992-07       Impact factor: 25.083

7.  Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes.

Authors:  M Hijikata; Y K Shimizu; H Kato; A Iwamoto; J W Shih; H J Alter; R H Purcell; H Yoshikura
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

9.  Cross-linking of Fc(gamma)-receptor on monocytes inhibits hepatitis C virus-specific cytotoxic T-lymphocyte induction in vitro.

Authors:  T Kanto; N Hayashi; T Takehara; K Katayama; A Ito; K Mochizuki; N Kuzushita; T Tatsumi; Y Sasaki; A Kasahara; M Hori
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

10.  Circulating immune complexes in chronic hepatitis C.

Authors:  J F Tsai; J E Jeng; W Y Chang; M S Ho; Z Y Lin; J H Tsai
Journal:  J Med Virol       Date:  1995-05       Impact factor: 2.327

View more
  3 in total

1.  Genetic variants of the IgA Fc receptor (FcalphaR, CD89) promoter in chronic hepatitis C patients.

Authors:  Azuma Watanabe; Toshibumi Shimokawa; Mitsuhiko Moriyama; Fumihiko Komine; Shuichi Amaki; Yasuyuki Arakawa; Chisei Ra
Journal:  Immunogenetics       Date:  2006-10-11       Impact factor: 2.846

2.  HCV enters the twenty-first century.

Authors:  Indira Brar; Dwayne Baxa; Norman Markowitz
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

Review 3.  Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence.

Authors:  Dennis Revie; Syed Zaki Salahuddin
Journal:  Virol J       Date:  2011-07-11       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.